Lord Kakkar
Main Page: Lord Kakkar (Crossbench - Life peer)I am grateful to my noble friend, who raises an important point. As I said, the UK has the most extensive immunisation programme in the world, with our vaccine confidence and uptake rates among the highest globally. However, we still have a lot of work to do on the communication of these outstanding products. NHS England’s Vaccination Strategy was published in December 2023; it sets out how the NHS and its partners will reduce morbidity and mortality from vaccine-preventable diseases by increasing vaccination uptake and coverage. The strategy outlines plans to maximise convenience for local communities, improve confidence and tackle complacency, by making every contact with local NHS services count. We all experienced the vaccination programme during Covid-19, and the NHS has learned from that by providing services locally so that people who find it difficult to travel around London or big cities have a convenient, familiar civic centre in which to get vaccinated. We have learned from Covid, but clearly we have a lot more to do.
My Lords, I draw noble Lords’ attention to my registered interests. Research, development and production of vaccines will increasingly represent an important part of our national security strategy. Is the Minister content that there is sufficient investment in those three elements to ensure that we can secure our biosecurity in the future?
The noble Lord is absolutely right to raise this. As I said in the previous answer that I gave to my noble friend, the Government are investing significantly in the manufacturing capacity and the supply chain within the United Kingdom. In the event of an emergency, we have a supply chain within the United Kingdom so that we can supply the vaccines needed for its population.